Discovery of Novel Glucagon Receptor Antagonists Using Combined Pharmacophore Modeling and Docking.

ABSTRACT: Glucagon and the glucagon receptor are most important molecules control over blood glucose concentrations. These two molecules are very important to studies of type 2 diabetic patients. In literature, several classes of small molecule antagonists of the human glucagon receptor have been reported. Glucagon receptor antagonist could decrease hepatic glucose output and improve glucose control in diabetic patients. In this research, to identify novel and diverse leads for use in potent glucagon receptor antagonist design, a ligand-based pharmacophore modeling, was developed using the best conformations of training set compounds. The best five features pharmacophore model, called Hypo1, includes, hydrogen bond acceptors, two hydrophobic, and positive ionizable features, which has the highest co

SUBMITTER: Jafari F 

PROVIDER: S-EPMC6269551 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature